Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Billion
04 12월 2023 - 3:47PM
Dow Jones News
By David Sachs
Roche aims to buy Carmot Therapeutics, a California-based
pharmaceutical firm developing drugs to treat obesity and
diabetes.
The Swiss pharmaceutical company said it has entered an
agreement to acquire the private company for $2.7 billion with
additional payments of up to $400 million based on drug-development
milestones.
The deal would give Roche access to Carmot's
research-and-development portfolio, including all clinical and
pretrial assets, Roche said. The portfolio includes drugs in
development to treat obesity as well as type-1 and type-2 diabetes,
Roche said.
Roche expects to close the transaction in the first quarter of
2024.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
December 04, 2023 01:32 ET (06:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Roche (QX) (USOTC:RHHBY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Roche Holdings Ltd AG (QX) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Roche Holdings Ltd AG (QX) News Articles